Jamie Kisgen
@kisgenuf.bsky.social
Husband | Girl Dad | ID pharmacist | Manager, Pharmacy Education and Clinical Research | PGY1 Residency Program Director
#GoGators #IDSky
#GoGators #IDSky
Reposted by Jamie Kisgen
📝Here are my cliff notes for the recently FDA approved drug #gepotidacin #blujepa
www.idstewardship.com/drugs/gepoti...
🤔 Still wondering where the name comes from? It’s a yellow tablet… Kind of sounds like Jet Blue 🤷♂️
Anything to add? #IDsky
www.idstewardship.com/drugs/gepoti...
🤔 Still wondering where the name comes from? It’s a yellow tablet… Kind of sounds like Jet Blue 🤷♂️
Anything to add? #IDsky
March 26, 2025 at 3:51 AM
📝Here are my cliff notes for the recently FDA approved drug #gepotidacin #blujepa
www.idstewardship.com/drugs/gepoti...
🤔 Still wondering where the name comes from? It’s a yellow tablet… Kind of sounds like Jet Blue 🤷♂️
Anything to add? #IDsky
www.idstewardship.com/drugs/gepoti...
🤔 Still wondering where the name comes from? It’s a yellow tablet… Kind of sounds like Jet Blue 🤷♂️
Anything to add? #IDsky
Reposted by Jamie Kisgen
🍄🍄Happy to share the link to free full text version of our new article in press: Current Antifungals and the Developing Pipeline with the fantastic @moorewjustin.bsky.social. #IDSky #PharmSky Thank you to the editors @drluiso.bsky.social @alukmd.bsky.social & Dr. Helen Boucher for the opportunity.
March 24, 2025 at 3:18 PM
🍄🍄Happy to share the link to free full text version of our new article in press: Current Antifungals and the Developing Pipeline with the fantastic @moorewjustin.bsky.social. #IDSky #PharmSky Thank you to the editors @drluiso.bsky.social @alukmd.bsky.social & Dr. Helen Boucher for the opportunity.
Reposted by Jamie Kisgen
The Baptist Health South Florida ID PGY2 Pharmacy Residency Program is available in phase 2 of the match. Please share with potential candidates 🙏 #IDsky
PGY2 Infectious Diseases Pharmacy Residency | Baptist Health
The PGY-2 Infectious Diseases Residency Program at Baptist Hospital is a 12-month pharmacy specialty-training program seeking accreditation form the American Society of Health System Pharmacists (ASHP...
baptisthealth.net
March 20, 2025 at 12:26 AM
The Baptist Health South Florida ID PGY2 Pharmacy Residency Program is available in phase 2 of the match. Please share with potential candidates 🙏 #IDsky
Reposted by Jamie Kisgen
Infectious Disease Society of America issues a statement on the political interference with the CDC vaccine information and the advisory committee on immunisation www.idsociety.org/news--public...
Statement on Removal of Vaccine Promotion and ACIP Meeting Postponement
www.idsociety.org
February 23, 2025 at 9:12 AM
Infectious Disease Society of America issues a statement on the political interference with the CDC vaccine information and the advisory committee on immunisation www.idsociety.org/news--public...
Reposted by Jamie Kisgen
📝 Here are cliff notes on the new FDA-approved product #Emblaveo
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
Aztreonam-avibactam (Emblaveo)
Aztreonam-avibactam (Emblaveo) photo source pfizer.nl KEY POINTS Aztreonam-avibactam (Emblaveo) is the combination of aztreonam (a monobactam) that interferes with bacterial cell wall synthesis and av...
www.idstewardship.com
February 9, 2025 at 6:52 PM
📝 Here are cliff notes on the new FDA-approved product #Emblaveo
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
Reposted by Jamie Kisgen
Yet another aspect of America that is the envy of the world is being destroyed by the Trump Administration: Universities.
At a minimum, these changes will lead to huge tuition increases and some closing, shifting research to other countries to benefit other citizens. America is dumbing down 1/
At a minimum, these changes will lead to huge tuition increases and some closing, shifting research to other countries to benefit other citizens. America is dumbing down 1/
1. Today the NIH director issued a new directive slashing overhead rates to 15%.
I want to provide some context on what that means and why it matters.
grants.nih.gov/grants/guide...
I want to provide some context on what that means and why it matters.
grants.nih.gov/grants/guide...
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
grants.nih.gov
February 8, 2025 at 2:10 AM
Yet another aspect of America that is the envy of the world is being destroyed by the Trump Administration: Universities.
At a minimum, these changes will lead to huge tuition increases and some closing, shifting research to other countries to benefit other citizens. America is dumbing down 1/
At a minimum, these changes will lead to huge tuition increases and some closing, shifting research to other countries to benefit other citizens. America is dumbing down 1/
Reposted by Jamie Kisgen
Thoughts for a Wednesday.
February 5, 2025 at 11:15 PM
Thoughts for a Wednesday.
Reposted by Jamie Kisgen
I ran @USAID health programs for the last 3 years. Trump’s 90 day Stop Work Order on foreign assistance does serious damage to the world and the US. Examples:🧵
January 26, 2025 at 3:56 PM
I ran @USAID health programs for the last 3 years. Trump’s 90 day Stop Work Order on foreign assistance does serious damage to the world and the US. Examples:🧵
PEN-FAST-ED
Check out our article on implementing the PEN-FAST scoring tool in the ED. Great way to identify patients who can be safely rechallenged. This has ripple effects beyond the ED.
Great work by our amazing PGY2 resident Kim and the EM pharmacy team!
www.sciencedirect.com/science/arti...
Check out our article on implementing the PEN-FAST scoring tool in the ED. Great way to identify patients who can be safely rechallenged. This has ripple effects beyond the ED.
Great work by our amazing PGY2 resident Kim and the EM pharmacy team!
www.sciencedirect.com/science/arti...
January 20, 2025 at 1:45 PM
PEN-FAST-ED
Check out our article on implementing the PEN-FAST scoring tool in the ED. Great way to identify patients who can be safely rechallenged. This has ripple effects beyond the ED.
Great work by our amazing PGY2 resident Kim and the EM pharmacy team!
www.sciencedirect.com/science/arti...
Check out our article on implementing the PEN-FAST scoring tool in the ED. Great way to identify patients who can be safely rechallenged. This has ripple effects beyond the ED.
Great work by our amazing PGY2 resident Kim and the EM pharmacy team!
www.sciencedirect.com/science/arti...
Reposted by Jamie Kisgen
journals.asm.org/doi/10.1128/...
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? | Antimicrobial Agents and Chemotherapy
There is a growing body of evidence supporting early transition to oral antibiotic
therapy to complete treatment courses for gram-negative bloodstream infections (GN-BSI)
(1–3). Most available data fo...
journals.asm.org
January 3, 2025 at 2:58 AM
journals.asm.org/doi/10.1128/...
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
Reposted by Jamie Kisgen
🔥🔥 NEW 🔥🔥
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Article Construction by: Timothy P. Gauthier, Pharm.D....
www.idstewardship.com
December 11, 2024 at 11:47 PM
🔥🔥 NEW 🔥🔥
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Reposted by Jamie Kisgen
Thanksgiving already! Time for an annual round-up of some ID things to be grateful for.
(Plus a bonus few non-ID items.)
Enjoy!
#IDSky
(Plus a bonus few non-ID items.)
Enjoy!
#IDSky
Some ID Things to Be Grateful for This Holiday Season — 2024 Edition
The calendar says it’s nearly the fourth Thursday of November, so here in the United States, the Thanksgiving holiday is upon us. It’s a day when we gather with family and friends to express thanks, t...
blogs.jwatch.org
November 27, 2024 at 5:26 PM
Thanksgiving already! Time for an annual round-up of some ID things to be grateful for.
(Plus a bonus few non-ID items.)
Enjoy!
#IDSky
(Plus a bonus few non-ID items.)
Enjoy!
#IDSky
Reposted by Jamie Kisgen
Inaugural article in a new section in @cidjournal.bsky.social called
“Clinical Dilemmas in Infectious Diseases”
led by IDMedEd superstars Daniel Minter and Varun Phadke designed to teach clinical reasoning
Rewriting the Script
academic.oup.com/cid/advance-... #IDSky
“Clinical Dilemmas in Infectious Diseases”
led by IDMedEd superstars Daniel Minter and Varun Phadke designed to teach clinical reasoning
Rewriting the Script
academic.oup.com/cid/advance-... #IDSky
Rewriting the Script
Natasha Spottiswoode, MD DPhil, Daniel J Minter, MD, Rachel Friedman-Moraco, MD; Rewriting the Script, Clinical Infectious Diseases, , ciae589, https://doi
academic.oup.com
November 27, 2024 at 2:00 PM
Inaugural article in a new section in @cidjournal.bsky.social called
“Clinical Dilemmas in Infectious Diseases”
led by IDMedEd superstars Daniel Minter and Varun Phadke designed to teach clinical reasoning
Rewriting the Script
academic.oup.com/cid/advance-... #IDSky
“Clinical Dilemmas in Infectious Diseases”
led by IDMedEd superstars Daniel Minter and Varun Phadke designed to teach clinical reasoning
Rewriting the Script
academic.oup.com/cid/advance-... #IDSky
Check out this amazing 🧵 below!
November 25, 2024 at 5:50 PM
Check out this amazing 🧵 below!
Reposted by Jamie Kisgen
1 out of every 7-8 Americans says they don’t have a regular source of healthcare, and 1 out of 12-13 Americans don’t have any health insurance. Americans spend an average of 7.3% of their annual income on healthcare. As a country, we are not upholding the Hippocratic oath. hbr.org/2024/11/why-...
Why the U.S. Healthcare System Is So Much Worse Than Its Peers
Given its collective wealth, technologic sophistication, and spending, the United States should lead, not lag, the world in its healthcare performance. But based on 70 performance measures across five...
hbr.org
November 25, 2024 at 4:39 AM
1 out of every 7-8 Americans says they don’t have a regular source of healthcare, and 1 out of 12-13 Americans don’t have any health insurance. Americans spend an average of 7.3% of their annual income on healthcare. As a country, we are not upholding the Hippocratic oath. hbr.org/2024/11/why-...
Reposted by Jamie Kisgen
November 21, 2024 at 12:16 AM
Reposted by Jamie Kisgen
🧫 “This mini-review examines the available antibiotics that exhibit activity against these organisms and provides guidance as to which cultures are relevant and how to treat active infections. Antibiograms describing resistance mechanisms...”
journals.asm.org/doi/10.1128/... ❤️ CMR #IDsky
journals.asm.org/doi/10.1128/... ❤️ CMR #IDsky
November 21, 2024 at 2:02 AM
🧫 “This mini-review examines the available antibiotics that exhibit activity against these organisms and provides guidance as to which cultures are relevant and how to treat active infections. Antibiograms describing resistance mechanisms...”
journals.asm.org/doi/10.1128/... ❤️ CMR #IDsky
journals.asm.org/doi/10.1128/... ❤️ CMR #IDsky
Reposted by Jamie Kisgen
New EMPHARMNET study-COPY-ED
Worried about cephalosporins in pyelonephritis? Fret not!
🧪 No difference in 14-day pyelonephritis treatment failure 💊for Ceph (n=647) vs FQ/TMP-SMX (n=204)
Love working with smart people to do cool things!
#MedSky #EMSky #IDSky
www.sciencedirect.com/science/arti...
Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study
The primary objective of our study was to compare the effectiveness of oral cephalosporins versus fluroquinolones and trimethoprim/sulfamethoxazole (T…
www.sciencedirect.com
November 21, 2024 at 1:14 AM
New EMPHARMNET study-COPY-ED
Worried about cephalosporins in pyelonephritis? Fret not!
🧪 No difference in 14-day pyelonephritis treatment failure 💊for Ceph (n=647) vs FQ/TMP-SMX (n=204)
Love working with smart people to do cool things!
#MedSky #EMSky #IDSky
www.sciencedirect.com/science/arti...
Reposted by Jamie Kisgen
You've probably heard that Bicarbonate has to turn into CO2 to raise the pH.
“Don’t give bicarb if you can’t increase ventilation.” But why?!
How much CO2 is there in an amp of sodium bicarbonate? Hos much does it raise pH? And how long does it last?
A 🧵 all about our ICU frenemy NaHCO3
1/
“Don’t give bicarb if you can’t increase ventilation.” But why?!
How much CO2 is there in an amp of sodium bicarbonate? Hos much does it raise pH? And how long does it last?
A 🧵 all about our ICU frenemy NaHCO3
1/
November 19, 2024 at 1:46 PM
You've probably heard that Bicarbonate has to turn into CO2 to raise the pH.
“Don’t give bicarb if you can’t increase ventilation.” But why?!
How much CO2 is there in an amp of sodium bicarbonate? Hos much does it raise pH? And how long does it last?
A 🧵 all about our ICU frenemy NaHCO3
1/
“Don’t give bicarb if you can’t increase ventilation.” But why?!
How much CO2 is there in an amp of sodium bicarbonate? Hos much does it raise pH? And how long does it last?
A 🧵 all about our ICU frenemy NaHCO3
1/
Reposted by Jamie Kisgen
What one billionaire did with a once-useful social media site gave me a new answer to the query, "What do you love to hate"?
More about the big migration to @bsky.app for ID docs here. h/t @johnrossmd.bsky.social @kenkoonwong.bsky.social @germhuntermd.bsky.social
blogs.jwatch.org/hiv-id-obser...
More about the big migration to @bsky.app for ID docs here. h/t @johnrossmd.bsky.social @kenkoonwong.bsky.social @germhuntermd.bsky.social
blogs.jwatch.org/hiv-id-obser...
Marking a Social Media Mass Migration -- Until the Next One
Periodically my wife and I will have a bunch of trainees (medical students, or residents, or ID fellows, or a mix) over to dinner. Seated around a big table, with no time-crunch of rounds, pagers, or ...
blogs.jwatch.org
November 18, 2024 at 3:52 PM
What one billionaire did with a once-useful social media site gave me a new answer to the query, "What do you love to hate"?
More about the big migration to @bsky.app for ID docs here. h/t @johnrossmd.bsky.social @kenkoonwong.bsky.social @germhuntermd.bsky.social
blogs.jwatch.org/hiv-id-obser...
More about the big migration to @bsky.app for ID docs here. h/t @johnrossmd.bsky.social @kenkoonwong.bsky.social @germhuntermd.bsky.social
blogs.jwatch.org/hiv-id-obser...
Reposted by Jamie Kisgen
We lack oral options for most MDR-GNB among current or upcoming antibiotics, so ambulatory care for these patients will relay largely on #OPAT.
The good news: most new agents are stable to be administered via infusion bags or elastomeric pumps 👉 www.mdpi.com/1999-4923/15...
#AMSsky #IDsky
The good news: most new agents are stable to be administered via infusion bags or elastomeric pumps 👉 www.mdpi.com/1999-4923/15...
#AMSsky #IDsky
November 17, 2024 at 11:33 AM
We lack oral options for most MDR-GNB among current or upcoming antibiotics, so ambulatory care for these patients will relay largely on #OPAT.
The good news: most new agents are stable to be administered via infusion bags or elastomeric pumps 👉 www.mdpi.com/1999-4923/15...
#AMSsky #IDsky
The good news: most new agents are stable to be administered via infusion bags or elastomeric pumps 👉 www.mdpi.com/1999-4923/15...
#AMSsky #IDsky
Reposted by Jamie Kisgen
🚨 Check out our amazing resources! We empower providers with weekly ABX pearls 💊—a hit with IM, RX, APPs! 👏 Plus, our ED PharmDs lead regular ABX talks at EM resident didactics. 🩺
👉 Explore our tools: med.stanford.edu/bugsanddrugs...
#medEd #AMSsky #IDsky #RXsky #PharmSky #TxID #Medsky
👉 Explore our tools: med.stanford.edu/bugsanddrugs...
#medEd #AMSsky #IDsky #RXsky #PharmSky #TxID #Medsky
November 15, 2024 at 3:01 PM